RICE-ibrutinib in Relapsed DLBCL (Q66392891)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RICE-ibrutinib in Relapsed DLBCL |
clinical trial |
Statements
A Phase II Study of Ibrutinib With R-ICE Chemotherapy for Transplant-eligible Relapsed/Refractory Diffuse Large B-cell Lymphoma Followed by Ibrutinib Maintenance in Patients Not Achieving a Complete Response at Pre-transplant Interim Assessment (English)
0 references
13 December 2016
0 references
August 2023
0 references
34
0 references
21 year
0 references
70 year
0 references